Agnieszka Gawlewicz‐Mroczka

Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity

Lucyna Mastalerz, Marek Sanak, Agnieszka Gawlewicz‐Mroczka et al. · Thorax · 2007 · 74 citations · Full text

Medicine, Internal Medicine, Pharmacology +13

Omalizumab may decrease the thickness of the reticular basement membrane and fibronectin deposit in the bronchial mucosa of severe allergic asthmatics

Weronika Zastrzeżyńska, Marek Przybyszowski, Stanisława Bazan‐Socha et al. · Journal of Asthma · 2019 · 33 citations · Full text

Medicine, Immunology, Pathology +17

Protection against exercise‐induced bronchoconstriction by montelukast in aspirin‐sensitive and aspirin‐tolerant patients with asthma

Lucyna Mastalerz, Agnieszka Gawlewicz‐Mroczka, Adam Ćmiel et al. · Clinical & Experimental Allergy · 2002 · 32 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Exhaled Eicosanoids following Bronchial Aspirin Challenge in Asthma Patients with and without Aspirin Hypersensitivity: The Pilot Study

Lucyna Mastalerz, Marek Sanak, Jagoda Kumik et al. · Journal of Allergy · 2012 · 27 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +12

Aspirin hypersensitivity diagnostic index (<scp>AHDI</scp>): In vitro test for diagnosing of N‐<scp>ERD</scp> based on urinary 15‐oxo‐<scp>ETE</scp> and <scp>LTE₄</scp> excretion

Lucyna Mastalerz, Gabriela Trąd, Piotr Szatkowski et al. · Allergy · 2024 · 15 citations · Full text

Medicine, Internal Medicine, Pharmacology +13